Education
About Us
Working with TipRanks
Follow Us
Allogene Therapeutics Inc (ALLO)
NASDAQ:ALLO
Allogene Therapeutics (ALLO) Ownership Overview
10.28% Insiders
11.89% Mutual Funds
17.59% Other Institutional Investors
7.79% ETFs
52.45% Public Companies and
Individual Investors
The ownership structure of Allogene Therapeutics (ALLO) stock is a mix of institutional, retail, and individual investors. Approximately 37.27% of the company’s stock is owned by Institutional Investors, 10.28% is owned by Insiders, and 52.45% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $203679 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $4795683 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $11151580 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,009,103 | Insider | 4.90% | 18,165,020 | |
| 8,139,840 | Institution | 3.62% | 13,430,736 | |
| 8,099,058 | Insider | 3.60% | 13,363,446 | |
| 8,000,345 | Institution | 3.56% | 13,200,569 | |
| 7,000,221 | Institution | 3.11% | 11,550,365 | |
| 6,571,030 | Institution | 2.92% | 10,842,200 | |
| 4,400,992 | Institution | 1.96% | 7,261,637 | |
| 4,360,608 | Institution | 1.94% | 7,195,003 | |
| 2,920,787 | Institution | 1.30% | 4,819,299 | |
| 2,611,403 | Institution | 1.16% | 4,308,815 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,571,030 | Institution | 2.92% | 10,842,200 | |
| 4,400,992 | Institution | 1.96% | 7,261,637 | |
| 2,611,403 | Institution | 1.16% | 4,308,815 | |
| 2,592,970 | Institution | 1.15% | 4,278,401 | |
| 1,717,422 | Institution | 0.76% | 2,833,746 | |
| 1,559,917 | Institution | 0.69% | 2,573,863 | |
| 1,235,040 | Institution | 0.55% | 2,037,816 | |
| 1,101,115 | Institution | 0.49% | 1,816,840 | |
| 851,203 | Institution | 0.38% | 1,404,485 | |
| 600,290 | Institution | 0.27% | 990,479 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,879,191 | Institution | 2.17% | 6,684,492 | |
| 3,832,968 | Institution | 1.71% | 6,324,397 | |
| 1,799,598 | Institution | 0.80% | 2,465,449 | |
| 1,336,977 | Institution | 0.59% | 2,206,012 | |
| 1,136,044 | Institution | 0.51% | 1,874,473 | |
| 781,288 | Institution | 0.35% | 1,289,125 | |
| 756,037 | Institution | 0.34% | 1,035,771 | |
| 464,287 | Institution | 0.21% | 766,074 | |
| 455,047 | Institution | 0.20% | 623,414 | |
| 338,611 | Institution | 0.15% | 558,708 |
FAQ
Who Owns Allogene Therapeutics Inc (ALLO)?
According to the latest TipRanks data, approximately 17.59% of the company's stock is held by institutional investors, 10.28% is held by insiders, and 52.45% is held by retail investors.
What percentage of Allogene Therapeutics Inc (ALLO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 17.59% of Allogene Therapeutics Inc (ALLO) stock is held by institutional investors.
What percentage of Allogene Therapeutics Inc (ALLO) stock is held by retail investors?
According to the latest TipRanks data, approximately 52.45% of Allogene Therapeutics Inc (ALLO) stock is held by retail investors.
Who owns the most shares of Allogene Therapeutics Inc (ALLO)?
Arie Belldegrun owns the most shares of Allogene Therapeutics Inc (ALLO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.